Analytics
Resolved No on 29 Jun 2025.
The last daily price before settlement had No at 89%. Yes opened at 62% on 18 Jun 2025. Before it settled, across the 12 daily closes on record from 18 Jun 2025 to 29 Jun 2025, the highest close was 80.5% on 19 Jun 2025 and the lowest 11% on 29 Jun 2025. Its largest one-day move was 31 points down, to 50% on 20 Jun 2025. $3.38K traded over the market's life.
2 wallets still hold shares. Winners redeem theirs after settlement, so what is left is mostly the losing side.
Polymarket record as of Jun 30, 4:24 PM UTC
Daily closes of the Yes price, Polymarket CLOB, 12 points, 18 Jun 2025 – 29 Jun 2025
| Observed | Yes price |
|---|---|
| 18 Jun 2025 | 62.0% |
| 29 Jun 2025 | 11.0% |
Winners have redeemed their shares, so most of what is left is the losing side.
| Trader | Outcome | Shares |
|---|---|---|
| potons | Yes | 14.29 |
| Frigid-Fog | No | 11.46 |
Open a trader’s name to inspect the wallet’s available P&L, positions and recorded trades, with source dates and coverage. A large position alone does not establish a winning track record.
This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants full or conditional approval for Unicycive Therapeutics’ new drug application (NDA) for Oxylanthanum Carbonate (OLC) as a treatment for hyperphosphatemia in patients with chronic kidney disease (CKD) by June 28, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No." This market will immediately resolve to "No" if the FDA issues a Complete Response Letter (CRL) or explicitly declines to approve the application. Conditional approvals may include post-marketing requirements or commitments and still qualify. The primary resolution source will be official information from the FDA, however a consensus of credible reporting may also be used.
Official listing: polymarket.com/event/fda-approves-unicycives-oxylanthanum-carbonate-olc
New to prediction markets? How to read a market page
